Cubist Named One of "Top Places to Work" by the Boston Globe for Fifth Consecutive Year
Cubist Named One of "Top Places to Work" by the Boston Globe for Fifth Consecutive Year
LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NAS: CBST) today announced that it has been named one of the Top Places to Work in Massachusetts in an annual employee-based survey from The Boston Globe. Cubist has been named to the list for five consecutive years - every year since the survey began in 2008.
"Cubist has grown significantly since opening its doors 20 years ago, yet our strong values and commitment to our culture remain constant," said Cubist CEO Michael Bonney. "Having our employees say that Cubist is a great place to work is one of the strongest compliments we can receive as an organization and is a source of great pride for me personally. Being recognized as one of Boston Globe's Top Places to Work is a reflection of the incredible people that make up our organization and the passion for our mission they bring every day."
The rankings were organized into four categories: Largest, Large, Medium, and Small companies. Cubist was ranked 20th in the Large employer category and is one of only 23 companies making the list for five years in a row. Rankings were based on composite scores calculated purely on the basis of employee responses. The Boston Globe Top Places to Work 2012 magazine was published in the Sunday Globe on November 4. Online, the report can be found at www.bostonglobe.com/topplaces and www.boston.com/topworkplaces.
"When we launched in 2008 during the Great Recession, we wondered if employers would lose focus on keeping their employees happy," Boston Globe Business Editor Shirley Leung said. "But businesses have continued to make strides in employee appreciation and opportunities. With more than 300 companies surveyed this year, we saw our highest participation rate to date."
The Boston Globe's 2012 Top Places to Work survey was conducted by WorkPlace Dynamics of Exton, Pa., specialists in employee engagement and retention. The Globe invited 1,586 employers to participate in the survey; 304 organizations employing a total of 210,000 people completed the process. Completed surveys were received from 81,907 individuals, who rated their employers based on workplace practices in compensation, leadership, appreciation, career opportunities and management.
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist's website.
About The Boston Globe:
The Boston Globe is wholly owned by the New York Times Company (NYS: NYT) , a leading global, multimedia news and information company with 2011 revenues of $2.3 billion, includes The New York Times, the International Herald Tribune, The Boston Globe, NYTimes.com, BostonGlobe.com, Boston.com and related properties. The Company's core purpose is to enhance society by creating, collecting and distributing high-quality news and information.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50465662〈=en
INVESTORS:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
MEDIA:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS:
The article Cubist Named One of "Top Places to Work" by the Boston Globe for Fifth Consecutive Year originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
